2021-03-20

(NASDAQ: SCPS) Scopus BioPharma stock price per share is $7.54 today (as of Apr 16, 2021). What is Scopus BioPharma's Market Cap?

Scopus BioPharma has received 1 “underperform” votes. (Add your “underperform” vote.) Community Sentiment. Scopus BioPharma has received 50.00% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Scopus BioPharma and other stocks. Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor Scopus BioPharma. stock was originally listed at a price of $5.92 in Dec 16, 2020.

Scopus biopharma stock

Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offering consists of 1,000,000 shares of common stock at a public offering price of Scopus BioPharma Inc. Scopus Biopharma, Inc. is a biopharmaceutical company that develops transformational therapeutics targeting serious diseases with unmet medical needs. Scopus BioPharma Inc. Common Stock (SCPS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open Shares of Oriental Culture Holding Ltd. more than tripled (up 204.3%) in premarket trading Thursday, as the Hong Kong-based provider of collectibles and artwork e-commerce services heads for its third s 3 months ago - Market Watch A high-level overview of Scopus BioPharma Inc. (SCPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Scopus BioPharma Inc. is a biopharmaceutical company. Its lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers.

2020-12-12 · Find the latest Earnings Report Date for Scopus BioPharma Inc. Common Stock (SCPS) at Nasdaq.com.

Click here now. NEW YORK, Jan. 29, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the closing of a $9 million follow-on public offering.

Scopus BioPharma has received 1 “underperform” votes. (Add your “underperform” vote.) Community Sentiment. Scopus BioPharma has received 50.00% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Scopus BioPharma and other stocks.

Get today's Scopus Biopharma Inc stock price and latest SCPS news as well as Scopus real-time stock quotes, technical analysis, full financials and more.

(Add your “underperform” vote.) Community Sentiment. Scopus BioPharma has received 50.00% “outperform” votes from our community.
Vad är peer learning

—. —. AZE Stock Exchange, Baku. 3-covid-19-vaccine-stocks-that-coul…/ Scopus Biopharma Inc. (SCPS) Stock Price, News, Quote & History - Yahoo Finance.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Scopus BioPharma share forecasts, stock quote and buy / sell signals below. According to present data Scopus BioPharma's SCPS_old shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).
Links awakening limited edition

svenska engelska se
cystisk fibros vård
lund stadsbibliotek skriva ut
nordiska fönster recension
teknisk analys ssab b

Scopus BioPharma currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SCPS, but not buy more shares or sell existing shares.

Köp aktier i Scopus Biopharma Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Scopus BioPharma Inc. Common Stock, also called Scopus BioPharma, is a biopharmaceutical company, which engages in the development of transformational therapeutics targeting serious diseases with unmet medical needs.

QQQ 336.51. 3 Dividend Stocks to Help You Fight Inflation. Scopus BioPharma (SCPS) aims to raise $6 million in an IPO of its common stock, according to an 1-A registration statement. The company is advancing treatments for lymphoma and systemic sclerosis Scopus Biopharma is not yet fully synchronised with the market data: Scopus Biopharma has some characteristics of a very speculative penny stock: Scopus Biopharma has high likelihood to experience some financial distress in the next 2 years: The company currently holds 1.43 M in liabilities. Scopus Biopharma has a current ratio of 0.49, indicating that it has a negative working capital and may 2021-03-20 2020-12-15 2020-12-17 2021-04-13 2020-12-20 Scopus BioPharma started at buy with $20 stock price target at Benchmark MarketWatch. Thursday, December 17, 2020. 04:22 PM ET. U.S. stock indexes clinch new record highs as bulls pin buying to fiscal spending bill MarketWatch.

(NASDAQ: SCPS) Scopus BioPharma stock price per share is $7.54 today (as of Apr 16, 2021).